A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...

A majority upheld part of the process used to create the package, but a Mercer analyst says there's more to the story.

Ruth Link-Gelles, PhD, MPH, of the CDC's National Center for Immunization and Respiratory Diseases, who has been leading the ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Brewer was terminated by Health and Human Services Sec. Robert F. Kennedy Jr. from the vaccine advisory panel in June.

Several northeastern states, including Maine, New York, Rhode Island and Connecticut, are considering forming the group to ...

In a matter of weeks, the credibility of the U.S. vaccine advisory panel has been upended after Kennedy removed all 17 of its ...

Legislative changes in states like Maine and Colorado aim to protect vaccine access and adapt to federal policy shifts ...